CAR T-Cell Therapy Delivers a Revelatory Experience for Myeloma Patient 

Linda Lane was still fatigued months after having COVID-19 in January of 2021.   “I told my doctor that I had not been this tired since I had a newborn in the house,” says Lane, now 57 and living on Cape Cod. “That got her attention.”  Her bloodwork came back with abnormal results. By May, the … Read more

Living with Multiple Myeloma, Doctor Becomes Powerful Resource and Patient Advocate 

Jim Omel, MD, helped many cancer patients during his long career as a family physician, and that has not changed since his own 1997 diagnosis with multiple myeloma. What has changed is the reach of his support.  While Omel, 77, cared for primarily farming families near his Nebraska clinic during 25-plus years in practice, his … Read more

Bispecific Antibodies for Multiple Myeloma: Six Things to Know 

 There are currently four bispecific antibodies approved by the U.S. Food and Drug Administration (FDA) for the treatment of multiple myeloma, including teclistamab, elranatamab, linvoseltamab and talquetamab. Since their FDA approvals, the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute has safely treated over 200 patients with bispecific antibodies for relapsed/refractory multiple myeloma. Bispecific antibodies represent one of the most … Read more